524558 Share Price Performance
₹18,422.80
4178.80 (29.34%)
12.2% undervalued intrinsic discount
₹20,972.00
Fair Value
Price ₹18,422.80
AnalystConsensusTarget ₹20,972.00
Fair Value₹20,972.00
Share Pricen/a
Narrative Update • Jun 13
Neuland Laboratories Limited Stock Price
- 1 Narratives written by author
- 0 Comments on narratives written by author
- 9 Fair Values set on narratives written by author
524558 Community Narratives
AN
Fair Value
·Fair Value ₹20.97k 12.2% undervalued intrinsic discount
524558: Leadership Changes And Board Decisions Will Shape The Next Phase
1users have liked this narrative
0users have commented on this narrative
4users have followed this narrative
524558: Leadership Changes And Board Decisions Will Shape The Next Phase
Neuland Laboratories is building more manufacturing capacity and leaning into harder-to-make drug ingredients, aiming to win new global customers as pharma companies rethink where they source key materials. But recent results show how uneven demand can be, and rising competition and tighter rules could make it harder to keep growth and profits on track.Read more
AN
₹20.97k
12.2% undervalued intrinsic discount
Fair Value
Revenue
19.15% p.a.
Profit Margin
21%
Future PE
49.88x
Price in 2029
₹27.89k
Trending Discussion
No trending discussion available.
Recently Updated Narratives
AN
524558: New Leadership And Transdermal CDMO Work Will Support Future Upside Potential
Fair Value: ₹20.97k 12.2% undervalued intrinsic discount
4 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
Snowflake Analysis
Neuland Laboratories Limited Key Details
Last Reported Earnings
Mar 31, 2026
Next Reporting Earnings
n/a
- 283.71
- 53.18%
- 17.99%
- 10.5%
About 524558
- Founded
- 1984
- Employees
- 2183
- CEO
- WebsiteView website
Neuland Laboratories Limited engages in the manufacture and sale of active pharmaceutical ingredients (APIs) in India, Europe, the United States, and internationally. It also provides custom manufacturing solutions, generic drug substances, as well as peptide APIs and synthesis services. The company serves generic companies, regional and domestic pharmaceutical manufacturers, distributors, and other pharmaceutical and biotechnology companies. Neuland Laboratories Limited was incorporated in 1984 and is headquartered in Hyderabad, India.
